As of June 30, 2024, BBS-Bioactive Bone Substitutes Oyj has 20.97M shares outstanding.
| Shares Outstanding | 20.97M |
As of June 30, 2024, BBS-Bioactive Bone Substitutes Oyj maintains a current ratio of 0.39, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.39 |
| Quick Ratio | 0.37 |
| Debt / Equity | 147.11 |
As of the close on March 10, 2025, BBS-Bioactive Bone Substitutes Oyj's stock has declined approximately 88.74% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.22.
| 52-Week Price Change | -88.74% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.22 |
BBS-Bioactive Bone Substitutes Oyj's most recent stock split took place on November 21, 2023 with a 1000:1049 split ratio.
| Last Split Date | 11/21/2023 |
| Split Ratio | 1000:1049 |
As of June 30, 2024, BBS-Bioactive Bone Substitutes Oyj has an Altman Z-Score of -20.53, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -20.53 |
Already premium?